IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Hiroshi Kogen

USPTO Granted Patents = 11

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 78(Granted Patents)


Location History:

  • Hiromachi, JP (1991 - 1997)
  • Tokyo, JP (1995 - 2000)

Company Filing History:

goldMedal11 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1991-2000

Loading Chart...
11 patents (USPTO):
1. 6040339 - Urea derivatives having ACAT inhibitory activity, their preparation and (2000-03-21),
2. 5880147 - Amide derivatives having ACAT inhibitory activity, their preparation and (1999-03-09),
3. 5827855 - Hexahydronaphthalene ester derivatives their preparation and their (1998-10-27),
4. 5658942 - Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition (1997-08-19),
5. 5614550 - Amide and urea derivatives having anti-hypercholesteremic activity, (1997-03-25),
6. 5604256 - Octahydronaphthalene oxime derivatives for cholesterol biosynthesis (1997-02-18),
7. 5534529 - Substituted aromatic amides and ureas derivatives having (1996-07-09),
8. 5491167 - Hexahydronaphthalene ester derivatives, their preparation and their (1996-02-13),
9. 5451688 - Hexahydronaphthalene ester derivatives, their preparation and their (1995-09-19),
10. 5403860 - Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition (1995-04-04),
11. 4997848 - Octahydronaphthalene oxime derivatives for cholesterol synthesis (1991-03-05),

Title: Innovations of Hiroshi Kogen

Introduction

Hiroshi Kogen is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with acyl-CoA: cholesterol acyl transferase (ACAT) inhibitory activity. With a total of 11 patents to his name, Kogen's work has the potential to impact the treatment of various health conditions.

Latest Patents

Kogen's latest patents include innovative urea derivatives and amide derivatives that exhibit valuable inhibitory activity against ACAT. These compounds are characterized by complex chemical structures, which include various alkyl and organic groups. The detailed formulations of these compounds highlight Kogen's expertise in medicinal chemistry and his commitment to advancing pharmaceutical science.

Career Highlights

Hiroshi Kogen is currently associated with Sankyo Company, Limited, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the industry. Kogen's dedication to innovation is evident in his extensive patent filings and ongoing research efforts.

Collaborations

Throughout his career, Kogen has collaborated with notable colleagues such as Teiichiro Koga and Sadao Ishihara. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in the field.

Conclusion

Hiroshi Kogen's contributions to pharmaceutical innovation through his patents and collaborations underscore his importance in the industry. His work continues to pave the way for advancements in medical treatments, showcasing the impact of dedicated inventors in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…